From detection to elimination: iron-based nanomaterials driving tumor imaging and advanced therapies

Bibliographic Details
Title: From detection to elimination: iron-based nanomaterials driving tumor imaging and advanced therapies
Authors: Dong Xie, Linglin Sun, Manxiang Wu, Qiang Li
Source: Frontiers in Oncology, Vol 15 (2025)
Publisher Information: Frontiers Media S.A., 2025.
Publication Year: 2025
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: iron-based nanomaterials, tumor imaging, magnetic hyperthermia, immunotherapy, artificial intelligence, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Iron-based nanomaterials (INMs), due to their particular magnetic property, excellent biocompatibility, and functionality, have been developed into powerful tools in both tumor diagnosis and therapy. We give an overview here on how INMs such as iron oxide nanoparticles, element-doped nanocomposites, and iron-based organic frameworks (MOFs) display versatility for tumor imaging and therapy improvement. In terms of imaging, INMs improve the sensitivity and accuracy of techniques such as magnetic resonance imaging (MRI) and photoacoustic imaging (PAI) and support the development of multimodal imaging platforms. Regarding treatment, INMs play a key role in advanced strategies such as immunotherapy, magnetic hyperthermia, and synergistic combination therapy, which effectively overcome tumor-induced drug resistance and reduce systemic toxicity. The integration of INMs with artificial intelligence (AI) and radiomics further expands its capabilities for precise tumor identification, and treatment optimization, and amplifies treatment monitoring. INMs now link materials science with advanced computing and clinical innovations to enable next-generation cancer diagnostics and therapeutics.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2234-943X
Relation: https://www.frontiersin.org/articles/10.3389/fonc.2025.1536779/full; https://doaj.org/toc/2234-943X
DOI: 10.3389/fonc.2025.1536779
Access URL: https://doaj.org/article/9fefae9b9c6f4e7d8430be0a2729cd39
Accession Number: edsdoj.9fefae9b9c6f4e7d8430be0a2729cd39
Database: Directory of Open Access Journals
More Details
ISSN:2234943X
DOI:10.3389/fonc.2025.1536779
Published in:Frontiers in Oncology
Language:English